Clinical Trial

Comparative Study of Rosuvastatin/Ezetimib 20/10 mg and Atovastatin/Ezetimib 40/10 mg (TOLERANT Trial)

Active, Not Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
the investigators would like to compare the differences between roschvastin and atovastatin in patients who require high-dose statin/ejetimib to undergo a new generation of drug elution stent implantation for cardiovascular disease and maintain LDL cholesterol below 55 mg/dL.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-06-14; most recent amendment 2025-11-20.
Status change: Recruiting → Active, Not Recruiting 2025-11-20
Trial Details
NCT Number NCT05910476
Lead Sponsor Yonsei University
Collaborators: dotter
Conditions Coronary Artery Disease, Dyslipidemias
Enrollment 200 participants
Start Date 2023-05-03
Primary Completion 2026-09-22 (estimated)
Study Completion 2026-09-22 (estimated)
Updated on ClinicalTrials.gov 2025-11-25